Laboratoires Thea SA - Company Profile
Powered by
All the data and insights you need on Laboratoires Thea SA in one report.
- Save hours of research time and resources with
our up-to-date Laboratoires Thea SA Strategy Report
- Understand Laboratoires Thea SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Laboratoires Thea SA (Thea) is a pharmaceutical company that researches, develops, manufactures, and commercializes a wide variety of eye care products. The company’s products find application in the diagnosis, surgery and treatment of ophthalmic diseases such as dry eye, allergies, glaucoma, ocular and eyelid hygiene, eye surgery, and violations of the posterior segment. Its product portfolio includes eye drops, ophthalmic gels, sterile compresses, and micellar solutions. Thea markets these products under the brand names Blephagel, Blephasteam, Nutrof, ABAK, Blephasol, and Blephaclean. The company markets products through sales organizations and distributors. Thea is headquartered in Clermont Ferrand, Auvergne, France.
Laboratoires Thea SA premium industry data and analytics
Products and Services
Products | Brands |
---|---|
- | Blephagel |
Ophthalmic Ointments: | Blephasteam |
Antiseptics and Antibiotics | Nutrof |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | Asset Purchase | In December, the company acquired late-stage ophthalmic assets, sepofarsen and ultevursen, from ProQR Therapeutics N.V. |
2023 | Others | In September, the company terminated the acquisition of Sepofarsen and Ultevursen Ophthalmic assets from ProQR Therapeutics. |
2023 | Contracts/Agreements | In September, Thea Open Innovation signed a partnership agreement with Link Biologics to develop Link_TSG6 for dry eyes. |
Competitor Comparison
Key Parameters | Laboratoires Thea SA | Alcon Inc | NicOx SA | Horus Pharma SAS | Ziemer Ophthalmic Systems AG |
---|---|---|---|---|---|
Headquarters | France | Switzerland | France | France | Switzerland |
City | Clermont Ferrand | Fribourg | Valbonne | Nice | Bern |
State/Province | Auvergne | Freiburg | Provence - Alpes- Cote d'Azur | Provence - Alpes- Cote d'Azur | Bern |
No. of Employees | - | 25,315 | 11 | - | - |
Entity Type | Private | Public | Public | Private | Private |
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Serge Resnikoff, M.D., Ph.D. | Chairman | Executive Board | - | - |
Henri Chibret | Director | Non Executive Board | - | - |
Jean-Frederic Chibret | Director | Non Executive Board | - | - |
Philippe Kestelyn | Director | Non Executive Board | - | - |
Didier Renault | Director | Non Executive Board | - | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward